Tianda Pharmaceuticals Limited

SEHK:455 Stock Report

Market Cap: HK$365.5m

Tianda Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 4/6

Tianda Pharmaceuticals has a total shareholder equity of HK$544.4M and total debt of HK$91.9M, which brings its debt-to-equity ratio to 16.9%. Its total assets and total liabilities are HK$804.8M and HK$260.3M respectively.

Key information

16.9%

Debt to equity ratio

HK$91.90m

Debt

Interest coverage ration/a
CashHK$103.77m
EquityHK$544.43m
Total liabilitiesHK$260.34m
Total assetsHK$804.77m

Recent financial health updates

Recent updates

Lacklustre Performance Is Driving Tianda Pharmaceuticals Limited's (HKG:455) 25% Price Drop

Oct 28
Lacklustre Performance Is Driving Tianda Pharmaceuticals Limited's (HKG:455) 25% Price Drop

Tianda Pharmaceuticals Limited (HKG:455) Investors Are Less Pessimistic Than Expected

Aug 16
Tianda Pharmaceuticals Limited (HKG:455) Investors Are Less Pessimistic Than Expected

Is Tianda Pharmaceuticals (HKG:455) Using Debt In A Risky Way?

Jun 20
Is Tianda Pharmaceuticals (HKG:455) Using Debt In A Risky Way?

There's Reason For Concern Over Tianda Pharmaceuticals Limited's (HKG:455) Massive 26% Price Jump

Mar 27
There's Reason For Concern Over Tianda Pharmaceuticals Limited's (HKG:455) Massive 26% Price Jump

Estimating The Fair Value Of Tianda Pharmaceuticals Limited (HKG:455)

Mar 02
Estimating The Fair Value Of Tianda Pharmaceuticals Limited (HKG:455)

Is Tianda Pharmaceuticals (HKG:455) Using Debt Sensibly?

May 23
Is Tianda Pharmaceuticals (HKG:455) Using Debt Sensibly?

Tianda Pharmaceuticals (HKG:455) Has Debt But No Earnings; Should You Worry?

Dec 06
Tianda Pharmaceuticals (HKG:455) Has Debt But No Earnings; Should You Worry?

Does Tianda Pharmaceuticals (HKG:455) Have A Healthy Balance Sheet?

Jan 11
Does Tianda Pharmaceuticals (HKG:455) Have A Healthy Balance Sheet?

Does Tianda Pharmaceuticals (HKG:455) Have A Healthy Balance Sheet?

Aug 05
Does Tianda Pharmaceuticals (HKG:455) Have A Healthy Balance Sheet?

Is Tianda Pharmaceuticals (HKG:455) Using Too Much Debt?

Dec 11
Is Tianda Pharmaceuticals (HKG:455) Using Too Much Debt?

Financial Position Analysis

Short Term Liabilities: 455's short term assets (HK$244.0M) do not cover its short term liabilities (HK$253.1M).

Long Term Liabilities: 455's short term assets (HK$244.0M) exceed its long term liabilities (HK$7.2M).


Debt to Equity History and Analysis

Debt Level: 455 has more cash than its total debt.

Reducing Debt: 455's debt to equity ratio has increased from 0% to 16.9% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 455 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: 455 has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 10% each year.


Discover healthy companies